John F. Rothrock
John F. Rothrock received his M.D. degree from the University of Virginia, Va, USA, in 1977. He completed his residency training in neurology at the University of Arizona, Ariz, USA, in 1981 and served on that institution’s faculty as an Assistant Professor for the subsequent two years. From 1983 to 1994 he served on the faculty on the Department of Neurosciences at the University of California San Diego (UCSD), Calif, USA, and during that time developed and directed the UCSD Stroke Center. Rothrock and his UCSD colleagues were instrumental in conducting research that led to the development of such widely used stroke therapies as tissue plasminogen activator (t-PA) and clopidogrel (Plavix). In 1989, he founded the UCSD Headache Center and assisted in the efforts to develop sumatriptan (Imitrex) and divalproex sodium (Depakote) as migraine therapies. From 1994 to 1999, Rothrock served as Chair of neurology at the College of Medicine, University of South Alabama, Ala, USA and subsequently as Professor of neurology and Associate Dean for clinical research. While at USA he established stroke and headache centers at that institution. In October 2006, Rothrock moved to the University of Alabama at Birmingham (UAB) to serve as Vice-Chair of neurology, and at UAB he continues to pursue his subspecialty interests in headache and stroke. Since 2001, Rothrock has served as an Editor-in-Chief for headache, the journal of the American Headache Society. Rothrock has been chosen by his peers for inclusion in both Best Doctors in America and America’s Top Doctors each of the past seven years. In 2007, he was cited as one of the nation’s top 20 neurologists by Men’s Health magazine and was cited similarly by Women’s Health magazine in 2008.
Biography Updated on 12 May 2009